Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends? (2018)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/pst.1845
PubMed Identifier: 29266692
Publication URI: http://europepmc.org/abstract/MED/29266692
Type: Journal Article/Review
Volume: 17
Parent Publication: Pharmaceutical statistics
Issue: 2
ISSN: 1539-1604